Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction

Hypertension

Volumn 46, Issue 5, 2005, Pages 1147-1153

  Didion, Sean P ^a   Kinzenbaw, Dale A ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Endothelium; Mice; Oxidative stress; Vessels

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; COPPER ZINC SUPEROXIDE DISMUTASE; ISOENZYME; SCAVENGER; SUPEROXIDE; TIRON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; CAROTID ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE DOSAGE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSMOLAR CONCENTRATION; SUPEROXIDE DISMUTASE; VASODILATION; VASODILATOR AGENTS;

EID: 27444436241     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000187532.80697.15     Document Type: Article

References (40)

1. Didion SP, Faraci FM, Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke. 2003; 34:2038-2042.
2. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM. Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol. 2002;283:H1569-H1576.
3. 1A receptor in mice. Hypertension. 2004;43:1074-1079.
4. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJV, Dominiczak AF. Investigation into the sources of Superoxide in human blood vessels: angiotensin II increases Superoxide production in human internal mammary arteries. Circulation. 2000;101:2206-2212.
5. Cifuentes ME, Rey FE, Carretero OA, Pagano PJ. Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin H-infused mice. Am J Physiol Heart Circ Physiol. 2000;279:H2234-H2240.
6. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
7. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Braz J Med Biol Res. 2004;37:1263-1273.
8. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab. In press.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
10. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of Superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
11. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin 11 in mice. Circ Res. 2001;88:947-953.
12. 2- and systolic blood pressure in mice. Circ Res. 2001;89:408-414.
13. Rey FE, Li XC, Carretero OA, Garvin JL, Pagano PJ. Perivascular Superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox). Circulation. 2002;106:2497-2502.
14. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004;109:1795-1801.
15. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:5H-515.
16. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular Superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res. 2003;93:622-629.
17. Faraci FM, Didion SP. Vascular protection: Superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004-24: 1367-1373.
18. Wang HD, Johns DG, Xu S, Cohen RA. Role of Superoxide anion in regulating presser and vascular hypertrophic response to angiotensin II. Am J Physiol. 2002;282:H1697-H1702.
19. Ryan MJ, Didion SP, Davis DR, Faraci FM, Sigmund CD. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler Thromb Vasc Biol. 2002;22:42-48.
20. Matzuk MM, Dionne L, Guo Q, Kumar TR, Lebovitz RM, Ovarian function in Superoxide dismutase 1 and 2 knockout mice. Endocrinology. 1998;139:4008-4011,
21. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA. 1987;84:8044-8048.
22. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased Superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002;91:938-944.
23. Didion SP, Kinzenbaw DA, Fegan PE, Didion LA, Faraci FM. Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke. 2004;35:1963-1967.
24. Didion SP, Faraci FM. Ceramide-induced impairment of endothelial function is prevented by CuZnSOD overexpression. Atheroscler Thromb Vasc Biol. 2005;25:90-95.
25. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998;274:H564-H570.
26. Didion SP, Faraci FM, Effects of NADH and NADPH on Superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002;282:H688-H695.
27. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol Heart Circ Physiol. 2001;281:H1697-H1703.
28. Didion SP, Sigmund CD, Faraci FM. Impaired endothelial function in transgenic mice expressing both human rennin and human angiotensinogen. Stroke. 2000;31:760-764.
29. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047-1055.
30. Kazama K, Anrather T, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004;95:1019-1026.
31. Key FE, Pagano PJ. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol. 2002;22:1962-1971.
32. Cooke CL, Davidge ST. Endothelial-dependent vasodilatation is reduced in mesenteric arteries from Superoxide dismutase knockout mice. Cardiovasc Res. 2003;60:635-642.
33. Veerareddy S, Cooke CL, Baker PN, Davidge ST. Gender differences in myogenic tone in superoxide dismutase knockout mouse: animal model of oxidative stress. Am J Physiol Heart Circ Physiol. 2004;287: H40-H45.
34. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet. 2004;20:136-145.
35. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999;2:157-161.
36. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lomardi S, Corrocher R. Anti-oxidant status of lipid peroxidation in patients with essential hypertension. J Hypertens. 1998;16:1267-1271.
37. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004;44:248-252.
38. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inuoe M. Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 1991;88:10045-10048.
39. Lassegue B, Griendling KK. Reactive oxygen species in hypertension: an update. Am J Hypertens. 2004;17:852-860.
40. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signaling by angiotensin II and vascular remodeling in hypertension. Clin Exp Pharmacol Physiol. 2003;30:860-866.